What happens when a pharmaceutical giant like Sanofi, a titan in the industry, unveils a drug that ticks all the clinical boxes yet leaves the market unimpressed? This is the perplexing reality surrounding Amlitelimab, an experimental treatment for eczema that promised to revolutionize patient care
In a remarkable stride for medical science, the survival rates for multiple myeloma, a significant form of blood cancer affecting thousands annually, have shown extraordinary improvement over recent decades. This disease, which accounts for roughly 2% of all cancer cases in the UK with about 6,300
The alarming underrepresentation of Black women in clinical trials, particularly in cancer research, stands as a critical public health issue that cannot be ignored, especially given their 38% higher likelihood of dying from breast cancer compared to other groups. Despite this stark statistic,
Diving into the forefront of biopharma innovation, I’m thrilled to sit down with Ivan Kairatov, a seasoned expert in the field with extensive experience in research and development. Ivan’s deep knowledge of cutting-edge technologies offers a unique perspective on the latest advancements in RNA
In a world where diabetes affects millions and places an immense strain on healthcare systems globally, a revolutionary approach to treatment has emerged from the Phase 3a ONWARDS 1–6 trials, showcasing the potential of Once-Weekly Insulin Icodec. This innovative therapy, distinct from the daily
In a remarkable stride toward modernizing healthcare, a clinical trial is underway to evaluate MORA Cure PFP, a cutting-edge digital therapy app designed to alleviate knee pain caused by patellofemoral pain syndrome (PFP), a condition marked by discomfort around or behind the kneecap. This ailment
